Eco Animal Health Group (FRA:LWA) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:LWA Eco Animal Health Group PLC FRA:LWA
71 GF Score
Price €0.97
GF Value €1.19
! 5 Warning Signs
View Full Analysis

What is Eco Animal Health Group Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

FRA:LWA
71GF Score
Eco Animal Health Group PLC FRA:LWA
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Eco Animal Health Group (FRA:LWA) Overvalued in 2026?

Based on GuruFocus' analysis, Eco Animal Health Group stock appears to be undervalued. The current stock price of €0.97 is trading 18.9% below its estimated GF Value™ of €1.19.

Key valuation signals for FRA:LWA:

  • Dividends Received:
  • GF Value™: €1.19 vs. price of €0.97 (18.9% below fair value)
  • GF Score™: 71/100 with 5 warning signs

No single metric tells the full story. See the FRA:LWA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Eco Animal Health Group Business Description

Other Exchanges EAH:UKLWA:Germany
Address 100 High street, The Grange, Southgate, London, GBR, N14 6BN
Eco Animal Health Group PLC is an animal health biotech company. It provides quality products for swine and poultry, anti-infectives to treat illness, improve health, and performance. Its products include Aivlosin/Valosin Solutions and Parasite Solutions. The company's segments include Corporate/UK, China and Japan, North America, South and Southeast Asia, Latin America, Europe, and the Rest of the World, with the majority of the revenue deriving from China and Japan.
71GF Score

Get the complete analysis for FRA:LWA

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.97
Price
€1.19
GF Value